References
- Serjeant GR. Sickle cell disease. Lancet 1997;350:725–730.
- Akinyanju OO. Sickle cell disorders. Niger Fam Pract 1994;3:24–30.
- Mohan JS, Lip GY, Bareford D, Blann AD. Plasma levels of tissue factor and insoluble E-selection in sickle cell disease: Relationship to genotype and to inflammation. Blood Coagul Fibrinolysis 2005;16:209–214.
- Ataga KI, Orringer EP. Hypercoagulability in sickle cell disease: A curios paradox. Am J Med 2003;115:721–728.
- Green D, Scott JP. Is sickle cell a thrombotic event? Am J Hematol 1986;23:317–321.
- Essien EM. Studies in haemostasis 1: The prothrombin time—its standardization and development of a national thrombo-plastin standard. Niger Med J 19788: 198–202.
- Famodu AA, Reid HL. Plasma fibrinogen level in sickle cell disease. Trop Geogr Med 1987;39:36–38.
- Famodu AA. Coagulation changes in homozygous sickle cell disease in Nigeria. J Clin Pathol 1987;40:1487.
- Fleming AF, Storey J, Molineaux L, Iroko EA, Attai EDE. Abnornal haemoglobins in the Sudan savannah of Nigeria 1. Prevalence of haemoglobin S and relationship between sickle cell trait, malaria and survival. Ann Trop Med Parasitol 1979;73: 161–172.
- Angelo A, Moons L, Bouche A, Shapiro SD. Coagulation testing in the clinical chemistry laboratory. J Int Fed Clin Chem 1991;5:62–73.
- Ansel J, Hirsh J, Dalen J, Bussey H, Poller L, Jacobson A, Deykin D, Matcher D. Managing oral anticoagulant therapy. Chest 2001;119( Suppl.):22S–23S.
- Robert-Dufour D, Lott GA, Nolte FS, Gretch DR, Koff RS, Seef LB. Diagnosis and monitoring of hepatic injury 11: Recommendations for use of laboratory test in screening, diagnosis and monitoring. Clin Chem 2000;46: 2050–2068.
- Booth SL, Centurelli MA. Vitamin K: A practical guide to the dietary management of patients on warfarin. Nutr Rev 1999;57:288–296.
- Giddings JC. Hereditary coagulation disorders: Laboratory techniques. In: Thomson JM, editor. Blood coagulation and haemostasis. A practical guide. 2nd ed. Edinburgh: Churchill Livingstone; 1980.
- Brown BA. Hematology: Principles and procedures. 5th ed. Philadelphia: Lea and Febiger.
- Leslie J, Langler D, Serjeant GR, Serjeant BE, Desai P, Gordon YB. Coagulation changes during the steady state in homozygous sickle cell disease. Br J Haematol 1975;30:159–166.
- Nsiri B, Gritli N, Bayoudh F, Messaoud T, Fattoum S, Machghoul S. Abnormalities of coagulation and fibrinolysis in homozygous sickle cell disoease. Hematol Cell Ther 1996; 38:279–284.
- Famodu AA, Adedeji MO, Reid HL. Serial plasma fibrinogen changes accompanying sickle cell pain crisis. Clin Lab Haematol 1990;12:43–47.
- Maurizio M, Cappucci G, Colaizzo D, Pirro L, Vecchione G, Grandone E, Di Minno G. Fibrinogen plasma levels in an apparently healthy general population—relation to environ-mental and genetic determinants. Thromb Haemost 1998; 80:805–810.